Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087806679> ?p ?o ?g. }
- W3087806679 endingPage "163" @default.
- W3087806679 startingPage "153" @default.
- W3087806679 abstract "Objective To investigate the impact of 68 Gallium prostate‐specific membrane antigen ( 68 Ga‐PSMA) tracers on the management of prostate cancer (PCa) patients with biochemical recurrence (BCR) by conducting a systematical review and meta‐analysis. Materials and Methods We performed a literature search of the PubMed, Embase and Web of Science databases up to 29 October 2019. We included studies that reported the proportion of patients whose management changed after 68 Ga‐PSMA tracers were used in patients with BCR. We used the Quality Assessment of Diagnostic Accuracy Studies‐2 tool to evaluate the quality of the included studies. The proportion of patients with management changes were pooled using a random‐effects model. Subgroup analyses and meta‐regression analyses were performed to explore the source of heterogeneity. A Sankey diagram was used to show treatment change from before to after the use of 68 Ga‐PSMA tracers. Results We included 20 eligible studies (2026 patients). The pooled proportion of patients with management change was 53% (95% confidence interval [CI] 46–60) in patients with BCR and 51% (95% CI, 34–67) in patients with early BCR (prostate‐specific antigen [PSA] <0.5 ng/mL). The pooled positron‐emission tomography‐positive rate in patients with BCR was 68% (95% CI 59–78). Fourteen studies reported management change, with most changes being intermodal in nature (42%, vs 17% intramodal change). Conclusions The use of 68 Ga‐PSMA tracers altered the management of more than half of PCa patients with BCR, including those with early BCR. 68 Ga‐PSMA tracers might be used to guide individualized treatment in patients with BCR, particularly those with early BCR." @default.
- W3087806679 created "2020-10-01" @default.
- W3087806679 creator A5017666843 @default.
- W3087806679 creator A5022903030 @default.
- W3087806679 creator A5043971382 @default.
- W3087806679 creator A5043989533 @default.
- W3087806679 date "2020-10-20" @default.
- W3087806679 modified "2023-10-12" @default.
- W3087806679 title "Impact of 68 Gallium prostate‐specific membrane antigen tracers on the management of patients with prostate cancer who experience biochemical recurrence" @default.
- W3087806679 cites W1903999661 @default.
- W3087806679 cites W1980053751 @default.
- W3087806679 cites W1995205917 @default.
- W3087806679 cites W2073988927 @default.
- W3087806679 cites W2145187141 @default.
- W3087806679 cites W2161374186 @default.
- W3087806679 cites W2211198407 @default.
- W3087806679 cites W2299477037 @default.
- W3087806679 cites W2403354006 @default.
- W3087806679 cites W2487033212 @default.
- W3087806679 cites W2510755861 @default.
- W3087806679 cites W2511755939 @default.
- W3087806679 cites W2598457068 @default.
- W3087806679 cites W2615655377 @default.
- W3087806679 cites W2673309218 @default.
- W3087806679 cites W2736737591 @default.
- W3087806679 cites W2737584987 @default.
- W3087806679 cites W2746662560 @default.
- W3087806679 cites W2766371188 @default.
- W3087806679 cites W2774325924 @default.
- W3087806679 cites W2782626231 @default.
- W3087806679 cites W2801398567 @default.
- W3087806679 cites W2802359738 @default.
- W3087806679 cites W2808437932 @default.
- W3087806679 cites W2809078634 @default.
- W3087806679 cites W2898441448 @default.
- W3087806679 cites W2900752862 @default.
- W3087806679 cites W2903357641 @default.
- W3087806679 cites W2903764711 @default.
- W3087806679 cites W2904772908 @default.
- W3087806679 cites W2910348604 @default.
- W3087806679 cites W2911188335 @default.
- W3087806679 cites W2913023403 @default.
- W3087806679 cites W2923116637 @default.
- W3087806679 cites W2924617625 @default.
- W3087806679 cites W2945553324 @default.
- W3087806679 cites W2966205719 @default.
- W3087806679 cites W2967355800 @default.
- W3087806679 cites W3012827461 @default.
- W3087806679 cites W3037257784 @default.
- W3087806679 doi "https://doi.org/10.1111/bju.15257" @default.
- W3087806679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32979229" @default.
- W3087806679 hasPublicationYear "2020" @default.
- W3087806679 type Work @default.
- W3087806679 sameAs 3087806679 @default.
- W3087806679 citedByCount "5" @default.
- W3087806679 countsByYear W30878066792021 @default.
- W3087806679 crossrefType "journal-article" @default.
- W3087806679 hasAuthorship W3087806679A5017666843 @default.
- W3087806679 hasAuthorship W3087806679A5022903030 @default.
- W3087806679 hasAuthorship W3087806679A5043971382 @default.
- W3087806679 hasAuthorship W3087806679A5043989533 @default.
- W3087806679 hasConcept C121608353 @default.
- W3087806679 hasConcept C126322002 @default.
- W3087806679 hasConcept C126894567 @default.
- W3087806679 hasConcept C143998085 @default.
- W3087806679 hasConcept C170493617 @default.
- W3087806679 hasConcept C20417620 @default.
- W3087806679 hasConcept C2776235491 @default.
- W3087806679 hasConcept C2777008409 @default.
- W3087806679 hasConcept C2779466945 @default.
- W3087806679 hasConcept C2780192828 @default.
- W3087806679 hasConcept C2781114028 @default.
- W3087806679 hasConcept C2781406297 @default.
- W3087806679 hasConcept C43907098 @default.
- W3087806679 hasConcept C44249647 @default.
- W3087806679 hasConcept C71924100 @default.
- W3087806679 hasConcept C95190672 @default.
- W3087806679 hasConceptScore W3087806679C121608353 @default.
- W3087806679 hasConceptScore W3087806679C126322002 @default.
- W3087806679 hasConceptScore W3087806679C126894567 @default.
- W3087806679 hasConceptScore W3087806679C143998085 @default.
- W3087806679 hasConceptScore W3087806679C170493617 @default.
- W3087806679 hasConceptScore W3087806679C20417620 @default.
- W3087806679 hasConceptScore W3087806679C2776235491 @default.
- W3087806679 hasConceptScore W3087806679C2777008409 @default.
- W3087806679 hasConceptScore W3087806679C2779466945 @default.
- W3087806679 hasConceptScore W3087806679C2780192828 @default.
- W3087806679 hasConceptScore W3087806679C2781114028 @default.
- W3087806679 hasConceptScore W3087806679C2781406297 @default.
- W3087806679 hasConceptScore W3087806679C43907098 @default.
- W3087806679 hasConceptScore W3087806679C44249647 @default.
- W3087806679 hasConceptScore W3087806679C71924100 @default.
- W3087806679 hasConceptScore W3087806679C95190672 @default.
- W3087806679 hasFunder F4320321001 @default.
- W3087806679 hasIssue "2" @default.
- W3087806679 hasLocation W30878066791 @default.
- W3087806679 hasOpenAccess W3087806679 @default.
- W3087806679 hasPrimaryLocation W30878066791 @default.